PT-141 nasal spray dose varies widely in research, with 10 mg and 20 mg most studied. Learn why no nasal product is FDA-approved and what to know.
There is no FDA-approved PT-141 nasal spray, so there is no official PT-141 nasal spray dose. Early clinical trials of intranasal bremelanotide most often studied 10 mg and 20 mg per dose, with a few using as little as 5 mg. Because the only approved form of bremelanotide is a 1.75 mg subcutaneous injection sold as Vyleesi, any nasal spray is compounded or research-grade and its actual strength can vary widely.
What PT-141 Is and Why People Ask About a Nasal Dose
PT-141 is the research name for bremelanotide, a melanocortin receptor agonist that affects sexual desire through the central nervous system rather than through blood flow alone. The FDA approved it in 2019 as Vyleesi, a subcutaneous injection for hypoactive sexual desire disorder (HSDD) in premenopausal women.
Before the injectable reached the market, researchers tested a nasal formulation in phase 2 trials for erectile dysfunction and female sexual dysfunction. Those trials helped establish the drug's effects, but the nasal product was never approved or commercialized.
Interest in a nasal route persists because it is needle-free, fast-acting, and easy to carry. Convenience does not equal standardization, though, and that gap is the core safety concern with any nasally delivered peptide.
PT-141 Nasal Spray Dose Ranges Reported in Research
Published studies of intranasal bremelanotide used a range of doses, and results did not always scale in a straight line. The table below summarizes the key differences between the approved injection and the nasal spray studied in research.
| Route | Typical dose | FDA status |
|---|---|---|
| Subcutaneous injection (Vyleesi) | 1.75 mg as needed, no more than once per day | Approved for HSDD in premenopausal women |
| Intranasal spray (clinical research) | 5 mg to 20 mg per dose; 10 mg and 20 mg most common | Not approved |
| Compounded nasal spray | No standard; varies by pharmacy and concentration | Not FDA-approved |
Two details matter when reading those numbers. Milligrams per spray depend entirely on the concentration a pharmacy or vendor mixes, so one spray from one product is not equal to one spray from another. Early trials also used single doses under clinic supervision, not repeated at-home use.
No standard nasal dose exists because no nasal product has been approved. Anyone weighing a pt-141 nasal spray vs injection is comparing an unregulated formulation with a regulated one.
Some sources focus on a pt-141 peptide nasal spray for men, since the earliest erectile dysfunction trials enrolled male participants. Those studies were small, and the nasal product was eventually abandoned in favor of the injection.
How to Use PT-141 Nasal Spray
If a clinician prescribes a compounded nasal spray, how to use pt-141 nasal spray generally follows a few practical steps:
- Prime the pump before first use, following the pharmacy's written instructions.
- Blow your nose gently to clear both nostrils.
- Insert the nozzle, aim slightly outward, and spray while breathing in softly.
- Avoid sniffing hard, which can pull the spray into your throat instead of your nasal lining.
- Wait roughly 45 minutes before sexual activity, based on timing data for the injection.
Do not use the spray more than once in 24 hours. Do not combine it with alcohol or blood pressure medications without medical guidance. Nausea is the most common reason people stop using bremelanotide.
Side Effects and Safety Considerations
Bremelanotide can raise blood pressure and cause nausea, flushing, and headache. The FDA label for Vyleesi warns about focal hyperpigmentation, a darkening of the skin, gums, or nails that can appear with repeated use.
Avoid PT-141 if you have uncontrolled hypertension, known cardiovascular disease, or a history of certain pigment disorders. People taking nitrates or other blood pressure drugs should ask a pharmacist about interactions before using any form of the drug.
Because no nasal spray is approved, the risks extend beyond the drug itself. Improperly prepared sprays may not be sterile, and the dose delivered per spray may be higher or lower than the label suggests.
Compounded Sprays, DIY Mixes, and Online Claims
Anyone searching for how to make pt-141 nasal spray should understand that reconstituting a peptide at home does not produce a sterile, dose-accurate nasal product. Compounding pharmacies can prepare nasal formulations with a prescription, but those preparations are not FDA-approved and their potency varies.
When people ask which is the best pt-141 nasal spray, the honest answer is that no brand has been reviewed or approved by the FDA. Vendor claims and forum anecdotes are impossible to verify and often describe products with unknown purity.
A nasal spray purchased without a prescription may contain no active peptide, the wrong concentration, or bacterial contamination. If you are considering one, discuss it with a licensed clinician and monitor your blood pressure.
Bottom Line on Dosing
PT-141 is not FDA-approved as a nasal spray in the United States. The only FDA-approved form of bremelanotide is a 1.75 mg subcutaneous injection, and no nasal equivalent has cleared that bar.
Early research most often used 10 mg and 20 mg intranasally, but those studies do not translate into a safe at-home dose. Anyone considering PT-141 in any form should talk with a licensed healthcare professional first.
Frequently Asked Questions
What is the typical PT-141 nasal spray dose?
No standard dose exists because no nasal spray has been approved. Early intranasal studies most commonly used 10 mg and 20 mg per dose, with a few using 5 mg. Compounded sprays vary by pharmacy, so the amount delivered per spray is not consistent between products.
Is PT-141 nasal spray FDA-approved?
No. The only FDA-approved bremelanotide product is Vyleesi, a 1.75 mg subcutaneous injection for hypoactive sexual desire disorder in premenopausal women. Nasal sprays sold online or made by compounding pharmacies are not FDA-approved.
How long before sex should you use PT-141 nasal spray?
The approved injection label suggests using it about 45 minutes before sexual activity. Nasal absorption may differ from injection, and no official timing exists for a nasal product. Ask a clinician for guidance if you are using a compounded spray.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.